SCHEMBL17366287

SCHEMBL17366287

CCCC(C)Oc1ccccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.48
ALDH1A1 P00352 3/20 0.44
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
HPGD P15428 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.39
HTR2C P28335 2/20 0.39
L3MBTL1 Q9Y468 3/20 0.38
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
SLC6A3 Q01959 2/20 0.38
SLC6A9 P48067 1/20 0.37
POLB P06746 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11838849 0.86 MCHR1 (0.54) MCHR1ALDH1A1ADRA2AADRA2BADRA2C
SCHEMBL11915275 0.85 MCHR1 (0.45) MCHR1ALDH1A1ADRA2AADRA2BADRA2C
SCHEMBL10408218 0.83 ALDH1A1 (0.45) ALDH1A1ADRA2AADRA2BADRA2CHPGD
SCHEMBL11708358 0.80 ALDH1A1 (0.43) ALDH1A1ADRA2AADRA2BADRA2CHPGD
SCHEMBL10866638 0.80 ADRA2A (0.44) ALDH1A1ADRA2AADRA2BADRA2CHPGD
SCHEMBL3162558 0.79 ADRA2A (0.43) ALDH1A1ADRA2AADRA2BADRA2CHPGD
SCHEMBL10408220 0.79 KMT2A (0.45) ALDH1A1ADRA2AADRA2BADRA2CHPGD
SCHEMBL10869047 0.78 MCHR1 (0.48) MCHR1ALDH1A1HPGDMAPTTAS1R3
SCHEMBL22513126 0.78 MCHR1 (0.48) MCHR1ADRA2AADRA2BADRA2CHPGD
SCHEMBL17366254 0.78 MCHR1 (0.48) MCHR1ALDH1A1HPGDSMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588451-B1 PIPERIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INT (DE) 2015-12-30 EP disclosed